Chugai Pharmaceutical Co Ltd (4519.T)
5,990JPY
16 Aug 2018
¥-60 (-0.99%)
¥6,050
¥6,050
¥6,100
¥5,960
787,500
758,127
¥6,210
¥4,220
Latest Key Developments (Source: Significant Developments)
Pharma Mar Reaches Early Termination Agreement With Chugai For Zepsyre
June 26 (Reuters) - Pharma Mar SA
Pharma Mar Says Chugai Terminates Licensing Agreement For Zepsyre In Japan
April 27 (Reuters) - Pharma Mar SA
CHUGAI PHARMACEUTICAL says filing of patent infringement lawsuit and petition for provisional disposition order
Jan 9 (Reuters) - CHUGAI PHARMACEUTICAL Co Ltd <4519.T> ::Says it filed an application for assisting intervention with Zenyaku Kogyo Co Ltd in a lawsuit that Genentech Inc filed, wherein the plaintiff demands prohibition of sales etc. of Rituxan® Injection, against Sandoz K.K and Kyowa Hakko Kirin Co Ltd.Says the company has also filed an application for assisting intervention in a petition for provisional disposition order that has been filed with the lawsuit. Full Article
Chiome Bioscience says termination of joint research contract
Dec 18 (Reuters) - Chiome Bioscience Inc <4583.T>:Says it announces termination of candidate antibody related joint research contract, which was signed between the co and CHUGAI PHARMACEUTICAL CO LTD <<<4519.T>>>, as the contract has expired on Dec. 31 . Full Article
Chugai Pharmaceutical says change of chief executive officer
Dec 12 (Reuters) - Chugai Pharmaceutical Co Ltd <4519.T>:Says it names current president and chief operating officer Tatsuro Kosaka as chief executive officer and president, effective late March 2018. Full Article
R&I affirms Chugai Pharmaceutical's rating at "AA-" and says stable outlook -R&I
Nov 16 (Reuters) - Chugai Pharmaceutical Co Ltd <4519.T>:Says Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "AA-" -R&I.Says rating outlook stable -R&I. Full Article
Marketing and manufacturing right transfer of 13 long-term listed products from Chugai Pharmaceutical to Taiyo Pharma
Nov 14 (Reuters) - Chugai Pharmaceutical Co Ltd <4519.T>:Says it and TAIYO HOLDINGS CO LTD <<<4626.T>>> announced today that they have entered into an agreement, under which the co and F. Hoffmann-La Roche, Ltd. will transfer the marketing authorizations, including marketing and manufacturing rights, of 13 long-term listed products manufactured and marketed in Japan by Chugai to TAIYO Pharma Co., Ltd., a wholly owned subsidiary of Taiyo Holdings. Full Article
Chugai Pharmaceutical to retire treasury shares
April 25(Reuters) - Chugai Pharmaceutical Co Ltd <4519.T>:Says it will retire 123,000 shares (0.02 percent of outstanding) of its common stock on April 28. Full Article
UPDATE 2-Takeda operating profit halves, looks to asset sales to shore up finances
* Shire-related costs helped push debt ratio higher (Adds details from news conference)
Earnings vs. 
Estimates